Patient Leaflet Updated 04-May-2021 | Eli Lilly and Company Limited
Strattera 4 mg/mL oral solution
Strattera® 4 mg/mL oral solution
atomoxetine
This medicine is used to treat ADHD
Before you take this medicine, talk to your doctor if you:
While taking this medicine:
Talk to your doctor straight away if any of the following happen:
The rest of this leaflet includes more detail and other important information on the safe and effective use of this medicine.
Sections 1 to 6 are for parents and carers (sometimes called ‘your guardians’).
The last section is a special section for a child or young person to read. However, all sections are written as though the child or young person taking the medicine is reading them.
1. What Strattera is and what it is used for
2. What you need to know before you take Strattera
3. How to take Strattera
4. Possible side effects
5. How to store Strattera
6. Contents of the pack and other information
Strattera contains atomoxetine and is used to treat attention-deficit and hyperactivity disorder (ADHD).
It is used
It is used only as a part of the total treatment of the disease which also requires treatments which do not involve medicines, such as counselling and behavioural therapy.
It is not for use as a treatment for ADHD in children under 6 years of age as it is not known if the drug works or is safe in these people.
In adults, Strattera is used to treat ADHD when the symptoms are very troublesome and affect your work or social life and when you have had symptoms of the disease as a child.
Strattera increases the amount of noradrenaline in the brain. This is a chemical that is produced naturally, and increases attention and decreases impulsiveness and hyperactivity in patients with ADHD. This medicine has been prescribed to help control the symptoms of ADHD. This medicine is not a stimulant and is therefore not addictive.
It may take a few weeks after you start the medicine for your symptoms to fully improve.
Children and young people with ADHD find it:
It is not their fault that they cannot do these things. Many children and young people struggle to do these things. However, with ADHD this can cause problems with everyday life. Children and young people with ADHD may have difficulty learning and doing homework. They find it hard to behave well at home, at school or in other places. ADHD does not affect the intelligence of a child or young person.
Adults with ADHD find it difficult to do all the things that children find difficult however this may mean they have problems with:
Do not take Strattera if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before you take Strattera. This is because Strattera can make these problems worse.
Both adult and children should be aware of the following warnings and precautions. Talk to your doctor or pharmacist before taking Strattera if you have:
Tell your doctor or pharmacist if any of the above applies to you before starting treatment. This is because Strattera can make these problems worse. Your doctor will want to monitor how the medicine affects you.
These checks are to decide if Strattera is the correct medicine for you.
Your doctor will measure your
Your doctor will talk to you about:
It is important that you provide as much information as you can. This will help your doctor decide if Strattera is the correct medicine for you. Your doctor may decide that other medical tests are needed before you start taking this medicine.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
This includes non-prescription medicines. Your doctor will decide if you can take Strattera with your other medicines and in some cases your doctor may need to adjust your dose or increase your dose much more slowly.
Do not take Strattera with medicines called MAOIs (monoamine oxidase inhibitors) used for depression. See section 2. “Do not take Strattera”.
If you are taking other medicines, Strattera may affect how well they work or may cause side effects. If you are taking any of the following medicines, check with your doctor or pharmacist before taking Strattera:
The medicines below may lead to an increased risk of an abnormal rhythm of the heart when taken with Strattera:
If you are not sure about whether any medicines you are taking are included in the list above, ask your doctor or pharmacist before taking Strattera.
It is not known if this medicine can affect an unborn baby or pass into breast milk.
If you are:
ask your doctor or pharmacist for advice before taking this medicine.
You may feel tired, sleepy or dizzy after taking Strattera. You should be careful if you are driving a car or operating machinery until you know how Strattera affects you. If you feel tired, sleepy or dizzy you should not drive or operate machinery.
This oral solution can irritate the eye. If the oral solution comes into contact with the eye, the affected eye should be flushed immediately with water, and medical advice obtained. Hands and any other part of the body that may have come into contact with the oral solution should also be washed as soon as possible.
This medicine contains 32.97 mg sorbitol in each mL. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.
This medicine contains 2.64 mg of sodium (main component of cooking/table salt) in each mL. This is equivalent to 3.3 % of the recommended maximum daily dietary intake of sodium for an adult.
This medicine contains 0.8 mg of sodium benzoate in each mL.
This medicine contains 9.8 mg of propylene glycol in each mL.
Strattera oral solution is available in a bottle. This is part of a pack which also includes a dosing device containing a 10 mL oral syringe marked in 1 mL increments and a press-in-bottle adaptor. Read the instructions for use booklet, which is included in the carton for instructions on how to use the adaptor and the dosing syringe.
If you are a child or teenager (6 years or older):
Your doctor will tell you how much Strattera you should take and will calculate this according to your weight. He/she will normally start you on a lower dose before increasing the amount of Strattera you need to take according to your body weight.
If you have problems with your liver your doctor may prescribe a lower dose.
If you take more Strattera than you should contact your doctor or the nearest hospital casualty department immediately and tell them how much medicine you have taken. The most commonly reported symptoms accompanying overdoses are gastrointestinal symptoms, sleepiness, dizziness, tremor, and abnormal behaviour.
If you miss a dose, you should take it as soon as possible, but you should not take more than your total daily dose in any 24-hour period. Do not take a double dose to make up for a forgotten dose.
If you stop taking Strattera there are usually no side effects but your ADHD symptoms may return. You should talk to your doctor first before you stop treatment.
Your doctor will do some tests
They will also be done when the dose is changed. These tests will include:
Strattera does not need to be taken for ever. If you take Strattera for more than a year, your doctor will review your treatment, to see if the medicine is still needed.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Although some people get side effects most people find that Strattera helps them. Your doctor will talk to you about these sides effects.
Some side effects could be serious. If you have any of the side effects below, see a doctor straight away.
Uncommon (may affect up to 1 in 100 people)
Adults have a reduced risk (may affect up to 1 in 1,000 people) of side effects such as:
Rarely (may affect up to 1 in 1,000 people)
Very common side effects (may affect more than 1 in 10 people)
CHILDREN and YOUNG PEOPLE over 6 years
These effects may disappear after a while in most patients.
ADULTS
Common side effects (may affect up to 1 in 10 people)
CHILDREN and YOUNG PEOPLE over 6 years
ADULTS
Uncommon side effects (may affect up to 1 in 100 people)
CHILDREN and YOUNG PEOPLE over 6 years
ADULTS
Rare side effects (may affect up to 1 in 1,000 people)
CHILDREN and YOUNG PEOPLE over 6 years
ADULTS
Some children experience reduced growth (weight and height) when they start taking Strattera. However, with long-term treatment, children recover to the weight and height for their age range. Your doctor will watch your child’s height and weight over time. If your child is not growing or gaining weight as expected, your doctor may change your child’s dose or decide to stop Strattera temporarily.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Ireland: via
or the United Kingdom (Great Britain and Northern Ireland):
or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton, and bottle after ‘Exp’. The expiry date refers to the last day of that month.
Do not use the oral solution more than 45 days after the first time you open the bottle.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment
Oral solution, 4 mg/mL (clear colourless)
Strattera oral solution is available in a bottle with a child resistant cap containing 100 mL of solution.
The pack also includes a dosing device consisting of a 10 mL oral syringe marked in 1 mL increments and a press-in-bottle adaptor.
Strattera oral solution is available in a pack containing one bottle and in a multipack of three bottles.
Not all pack sizes may be marketed.
The marketing authorisation holder is:
The manufacturer is:
Strattera is a trademark of Eli Lilly and Company Limited.
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria, Denmark, Germany, Hungary, Iceland, the Republic of Ireland, Italy, Malta, Norway, Portugal, Romania, Slovenia, Spain, Sweden and the UK: Strattera.
This leaflet was last revised in January 2021
For information about this product, please contact:
Detailed information on this medicine is available on the web site of: UK/MHRA, Ireland/HPRA
ST048
Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA
https://www.lilly.com/uk/
https://www.lillymedical.co.uk/en-gb